Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX)

CAPS Rating: 2 out of 5

A development-stage pharmaceutical company focused on the acquisition, development and commercialization of prescription drugs for the treatment of drug addiction.

Recs

0
Player Avatar pchop123 (76.53) Submitted: 9/17/2012 11:08:15 AM : Outperform Start Price: $1.48 CPRX Score: +29.94

more upsdie forthcoming

Featured Broker Partners


Advertisement